Their primary business activity is to invest funds with the objective of achieving appreciation of capital invested.
Their primary business activity is to invest funds to achieve an appreciation of the capital invested.
Further, before the proposed combination, GSKAPL will acquire the trademarks about “Iodex†and “Ostocalcium†brands in India .
Sun Pharma performed as top gainer surging by 3% after hitting 52-week high Rs861.50 per piece.
Lupin, Divis Lab, and Sun Pharma added to the gains. Gland Pharma and Auro Pharma were under extreme pressure.
The scheme is subject to the requisite statutory approvals including the approval of the NCLT, CCI, etc.
Pursuant to this, Dash will become a 100% wholly-owned subsidiary of NATCO Pharma Inc. and a step-down subsidiary of NATCO.
Strides Pharma and Natco Pharma led the gains to lend support to the sector.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
